{{$root.universalMessage.text}}

Washington HB1216

Concerning insurance coverage of treatment of eosinophilia gastrointestinal associated disorders. Revised for 1st Substitute: Concerning sunrise review for a proposal to establish a mandated benefit of treatment of eosinophilia gastrointestinal associated disorders. (REVISED FOR PASSED LEGISLATURE: Concerning treatment of eosinophilia gastrointestinal associated disorders. )